CXCR3 and cancer: Hirth et al. identified that chemokines, specifically CXCL10 and CCL21, can mediate cancer cell interaction, contributing to NI, nerve fiber hypertrophy and cancer pain through CXCR3 and CCR7 receptors expressed on PDAC cells (Hirth et al., 2020).